Predict COPD exacerbation with acoustic analysis
A smartphone-based test for patients with Chronic Obstructive Pulmonary Disease (COPD) to monitor disease progression and predict exacerbations.
60%
ED visits for COPD exacerbations could be prevented
55%
Are due to delayed recognition of symptoms or healthcare access
€3.7Trillion
Global economic burden (2020–2050)
Most exacerbations are detected too late
Chronic Obstructive Pulmonary Disease (COPD) patients manage their disease at home using a self-reported questionnaire and a pulse oximeter. More than 60% of their visit to the Emergency Department (ED) for exacerbation could be prevented, mostly by supporting patients in understanding their disease and accessing health information.
Detect worsening earlier,
act at the right time
Welcome VoiceMed Predict for COPD
It transforms subtle physiological changes into actionable signals, helping patients and care teams intervene before escalation.
Breathe and speak
Perform three deep breaths and a short vocalization. Acoustic biomarkers capture early signs of worsening.
Anywhere, anytime
VoiceMed Predict for COPD is accessible from any RPM platform that integrates this technology or from our app.
Timely action
Receive a clear indication of disease worsening. Understand whether to seek medical evaluation.
Clinical validation an ongoing studies
VoiceMed Predict for COPD is currently being evaluated in longitudinal studies tracking patients over 12 months. Results expected in 2027.
- Predictive performance for exacerbations
- Impact on healthcare utilization
- Usability and adherence
Who benefits the most
Remote Patient Monitoring platforms
Pulmonologists
Hospitals managing COPD patients
Pharma companies
Objective monitoring, beyond symptom perception
Current COPD management relies heavily on subjective symptom perception and saturation, often leading to delayed intervention. VoiceMed introduces a physiology-based trigger for action.
Fully digital
No hardware required, works on any smartphone
Objective detection
Measure disease signals through acoustic biomarkers
Fast and repeatable
Complete the test in under one minute, anytime
From signal to action
If worsening is detected, patients are prompted to contact a physician for evaluation
Aiming at generating a positive impact
- earlier medical intervention
- reduction in avoidable emergency visits
- improved disease management and patient outcomes
Easy to integrate, secure, and on the regulatory pathway
SDK & API integration
Test accessible through our app or by integrating it into third party app with SDK / API on iOS and Android, typically completed in one day.
GDPR-compliant and securely hosted in Europe
All data is handled in full compliance with GDPR requirements and securely hosted on European infrastructure.
Medical device pathway
Our software is being developed as a Class IIa medical device under the European MDR framework, with certification underway.
Let’s work together
- Pilot to expand clinical validation in other geographies,
- Contact us to sign up for buying the solution once it reaches certification. We offer a special promotion when a clear letter of intent is signed.